SCHEMBL9564923

SCHEMBL9564923

Cc1ccc(S(=O)(=O)O)cc1.OCC1COc2ccccc2O1

nearest known ligand 0.62

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.62
SMN1; SMN2 Q16637 2/20 0.59
RAB9A P51151 1/20 0.53
POLB P06746 1/20 0.50
CA2 P00918 4/20 0.48
MTNR1A P48039 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HTT P42858 1/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 1/20 0.45
GAA P10253 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9316602 0.85 CA2 (0.58) LMNASMN1; SMN2RAB9APOLBCA2
SCHEMBL11089452 0.83 LMNA (0.53) LMNASMN1; SMN2RAB9APOLBL3MBTL1
SCHEMBL9582651 0.80 LMNA (0.67) LMNASMN1; SMN2RAB9APOLBCA2
SCHEMBL30640286 0.80 ADRA2A (0.60) SMN1; SMN2RAB9APOLBCA2MTNR1A
SCHEMBL568115 0.80 ADRA2A (0.60) SMN1; SMN2RAB9APOLBCA2MTNR1A
SCHEMBL3266284 0.80 ADRA2A (0.60) SMN1; SMN2RAB9APOLBCA2MTNR1A
SCHEMBL407539 0.80 ADRA2A (0.60) SMN1; SMN2RAB9APOLBCA2MTNR1A
SCHEMBL8864506 0.80 CA2 (0.49) LMNASMN1; SMN2RAB9ACA2ALDH1A1
SCHEMBL9699068 0.80 LMNA (0.43) LMNASMN1; SMN2POLBL3MBTL1ALDH1A1
SCHEMBL9701618 0.79 GAA (0.45) LMNASMN1; SMN2RAB9APOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5258380-A Antiallergens, antihistamines JANSSEN PHARMACEUTICA N.V. (BE) 1993-11-02 US disclosed
EP-0206415-B1 (4-PIPERIDINYLMETHYL AND -HETERO)PURINES JANSSEN PHARMACEUTICA N.V. (BE) 1993-01-27 EP disclosed
WO-1992006086-A1 NOVEL 4-PIPERIDINYLCARBONYL DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-04-16 WO disclosed
US-5041448-A Antiallergens JANSSEN PHARMACEUTICA N.V. (BE) 1991-08-20 US disclosed
EP-0199400-B1 Substituted N-[(4-piperidinyl)alkyl] bicyclic condensed ozazol- and thiazolamines JANSSEN PHARMACEUTICA N.V. (BE) 1990-09-26 EP disclosed
US-4826848-A Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines JANSSEN PHARMACEUTICA N.V. (BE) 1989-05-02 US disclosed
US-4689330-A PARKINSON DISEASE JANSSEN PHARMACEUTICA N.V. (BE) 1987-08-25 US disclosed
EP-0206415-A2 (4-Piperidinylmethyl and -hetero)purines JANSSEN PHARMACEUTICA N.V. (BE) 1986-12-30 EP disclosed
EP-0199400-A2 Substituted N-[(4-piperidinyl)alkyl] bicyclic condensed ozazol- and thiazolamines JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-29 EP disclosed
US-4500543-A Substituted 1-aminomethyl-phthalans ABBOTT LABORATORIES (US) 1985-02-19 US disclosed
US-4473586-A Aminoalkyl dihydronaphthalenes ABBOTT LABORATORIES (US) 1984-09-25 US disclosed